These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8389086)

  • 1. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
    Leprince D; Crepieux P; Laudet V; Flourens A; Stehelin D
    Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
    Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
    Leprince D; Crepieux P; Stehelin D
    Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
    Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
    Reddy ES; Rao VN
    Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages.
    Domenget C; Leprince D; Pain B; Peyrol S; Li RP; Stehelin D; Samarut J; Jurdic P
    Oncogene; 1992 Nov; 7(11):2231-41. PubMed ID: 1331935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
    Reddy ES; Rao VN
    Cancer Res; 1990 Aug; 50(16):5013-6. PubMed ID: 2165853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features.
    Albagli O; Flourens A; Crepieux P; Begue A; Stehelin D; Leprince D
    Oncogene; 1992 Jul; 7(7):1435-9. PubMed ID: 1620554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chicken cellular progenitor of the v-ets oncogene, p68c-ets-1, is a nuclear DNA-binding protein not expressed in lymphoid cells of the spleen.
    Leprince D; Gesquiere JC; Stehelin D
    Oncogene Res; 1990; 5(4):255-65. PubMed ID: 2204018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets oncogene family.
    Dhulipal PD
    Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo.
    Quéva C; Leprince D; Stéhelin D; Vandenbunder B
    Oncogene; 1993 Sep; 8(9):2511-20. PubMed ID: 8361762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
    Hahn SL; Wasylyk B
    Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino-acid substitution in the DNA-binding domain of the myb oncogene confers a thermolabile phenotype to E26-transformed myeloid cells.
    Li RP; Duterque-Coquillaud M; Lagrou C; Debuire B; Graf T; Stehelin D; Leprince D
    Oncogene Res; 1989; 5(2):137-41. PubMed ID: 2608278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
    Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
    Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dissection of the transcription factor Elk-1.
    Janknecht R; Zinck R; Ernst WH; Nordheim A
    Oncogene; 1994 Apr; 9(4):1273-8. PubMed ID: 8134131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.